Arctic Bioscience AS (OSL: ABS)
Norway
· Delayed Price · Currency is NOK
2.080
-0.060 (-2.80%)
Nov 21, 2024, 4:25 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 52.77 million as of November 21, 2024. Its market cap has decreased by -78.47% in one year.
Market Cap
52.77M
Enterprise Value
34.70M
Revenue
31.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.08
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 52.77M, a decrease of -92.10%. That is a compound annual growth rate of -49.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 54.29M | -79.62% |
Dec 29, 2023 | 266.38M | -7.39% |
Dec 30, 2022 | 287.63M | -33.50% |
Dec 30, 2021 | 432.53M | -35.27% |
Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nordhealth AS | 2.96B |
Medistim ASA | 2.55B |
Carasent ASA | 1.45B |
Photocure ASA | 1.34B |
Nykode Therapeutics AS | 898.00M |
ArcticZymes Technologies ASA | 673.12M |
Gentian Diagnostics ASA | 635.40M |
Thor Medical ASA | 554.27M |